↓ Skip to main content

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma

Overview of attention for article published in BMC Cancer, December 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
2 news outlets
twitter
2 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma
Published in
BMC Cancer, December 2021
DOI 10.1186/s12885-021-09097-5
Pubmed ID
Authors

Ross S. Greenberg, Jake A. Ruddy, Brian J. Boyarsky, William A. Werbel, Jacqueline M. Garonzik-Wang, Dorry L. Segev, Philip H. Imus

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 9 16%
Student > Master 6 10%
Researcher 3 5%
Professor > Associate Professor 3 5%
Student > Ph. D. Student 3 5%
Other 7 12%
Unknown 27 47%
Readers by discipline Count As %
Medicine and Dentistry 13 22%
Nursing and Health Professions 5 9%
Agricultural and Biological Sciences 2 3%
Biochemistry, Genetics and Molecular Biology 2 3%
Engineering 2 3%
Other 6 10%
Unknown 28 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2023.
All research outputs
#2,401,041
of 24,350,163 outputs
Outputs from BMC Cancer
#426
of 8,650 outputs
Outputs of similar age
#58,152
of 508,666 outputs
Outputs of similar age from BMC Cancer
#16
of 227 outputs
Altmetric has tracked 24,350,163 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,650 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 508,666 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 227 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.